- Report
- February 2026
- 250 Pages
Global
From €3968EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €3968EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €3968EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €3968EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €3968EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €3968EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €3968EUR$4,490USD£3,436GBP
- Report
- October 2025
- 250 Pages
Global
From €3968EUR$4,490USD£3,436GBP
- Report
- January 2026
- 146 Pages
Global
From €3491EUR$3,950USD£3,023GBP
- Report
- January 2026
- 140 Pages
Global
From €3491EUR$3,950USD£3,023GBP
- Report
- January 2026
- 150 Pages
Global
From €4286EUR$4,850USD£3,712GBP
- Report
- November 2025
- 150 Pages
Global
From €4286EUR$4,850USD£3,712GBP
- Report
- June 2025
- 194 Pages
Global
From €4374EUR$4,950USD£3,788GBP
- Report
- October 2025
- 89 Pages
Middle East
From €4286EUR$4,850USD£3,712GBP
- Report
- August 2024
- 307 Pages
Global
From €4374EUR$4,950USD£3,788GBP
- Report
- May 2023
- 202 Pages
Global
From €4374EUR$4,950USD£3,788GBP
- Report
- July 2023
- 257 Pages
Global
From €4374EUR$4,950USD£3,788GBP
- Report
- September 2023
- 227 Pages
Global
From €3689EUR$4,175USD£3,195GBP
- Report
- November 2024
- 84 Pages
Global
From €4109EUR$4,650USD£3,559GBP
- Report
- December 2024
- 61 Pages
Europe
From €2872EUR$3,250USD£2,487GBP

Targeted sequencing is a type of genomics technology that focuses on specific regions of the genome. It is used to identify genetic variants associated with diseases, to detect mutations in cancer, and to study gene expression. Targeted sequencing is a cost-effective alternative to whole-genome sequencing, as it requires less sequencing and data analysis. It is also used in clinical diagnostics, drug discovery, and agricultural research.
Targeted sequencing is a rapidly growing market, driven by advances in sequencing technology and the increasing demand for personalized medicine. Companies in the market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10x Genomics. Show Less Read more